133 related articles for article (PubMed ID: 36722609)
1. Identification of irritable bowel syndrome in the Swedish National Patient Register: a validation study.
Tornkvist NT; Backman AS; Linder M; Altman M; Simrén M; Olén O; Törnblom H
Scand J Gastroenterol; 2023 Jul; 58(7):709-717. PubMed ID: 36722609
[TBL] [Abstract][Full Text] [Related]
2. Fecal incontinence in irritable bowel syndrome: Prevalence and associated factors in Swedish and American patients.
Simrén M; Palsson OS; Heymen S; Bajor A; Törnblom H; Whitehead WE
Neurogastroenterol Motil; 2017 Feb; 29(2):. PubMed ID: 27581702
[TBL] [Abstract][Full Text] [Related]
3. Validity and reliability of the Malay-language translation of the Rome III Diagnostic Questionnaire for irritable bowel syndrome.
Lee YY; Waid A; Tan HJ; Chua SB; Whitehead WE
J Gastroenterol Hepatol; 2012 Apr; 27(4):746-50. PubMed ID: 22004172
[TBL] [Abstract][Full Text] [Related]
4. Applying case definition criteria to irritable bowel syndrome.
Yale SH; Musana AK; Kieke A; Hayes J; Glurich I; Chyou PH
Clin Med Res; 2008 May; 6(1):9-16. PubMed ID: 18591372
[TBL] [Abstract][Full Text] [Related]
5. Pre- and perinatal stress and irritable bowel syndrome in young adults - A nationwide register-based cohort study.
Olén O; Stephansson O; Backman AS; Törnblom H; Simrén M; Altman M
Neurogastroenterol Motil; 2018 Nov; 30(11):e13436. PubMed ID: 30084125
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis of Irritable Bowel Syndrome: Primary Care Physicians Compared with Gastroenterologists.
Pareki G; Wozniak A; Abegunde AT
Clin Med Res; 2023 Sep; 21(3):129-135. PubMed ID: 37985167
[No Abstract] [Full Text] [Related]
7. Prevalence and impact of Rome IV versus Rome III irritable bowel syndrome in patients with inflammatory bowel disease.
Fairbrass KM; Selinger CP; Gracie DJ; Ford AC
Neurogastroenterol Motil; 2022 May; 34(5):e14256. PubMed ID: 34472157
[TBL] [Abstract][Full Text] [Related]
8. Comparisons of the Rome III and Rome IV criteria for diagnosis of irritable bowel syndrome in Indian and Bangladeshi communities and internal shifts in the diagnostic categories of bowel disorders of gut-brain interactions.
Ghoshal UC; Rahman MM; Pratap N; Misra A; Sarker SA; Hasan M; Bangdiwala SI; Palsson OS; Sperber AD
Neurogastroenterol Motil; 2023 Jun; 35(6):e14579. PubMed ID: 37010834
[TBL] [Abstract][Full Text] [Related]
9. Patients suspected of irritable bowel syndrome--cross-sectional study exploring the sensitivity of Rome III criteria in primary care.
Engsbro AL; Begtrup LM; Kjeldsen J; Larsen PV; de Muckadell OS; Jarbøl DE; Bytzer P
Am J Gastroenterol; 2013 Jun; 108(6):972-80. PubMed ID: 23419383
[TBL] [Abstract][Full Text] [Related]
10. Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: a systematic review and meta-analysis.
Oka P; Parr H; Barberio B; Black CJ; Savarino EV; Ford AC
Lancet Gastroenterol Hepatol; 2020 Oct; 5(10):908-917. PubMed ID: 32702295
[TBL] [Abstract][Full Text] [Related]
11. [Irritable bowel syndrome in the Russian Federation: results of the ROMERUS multicenter observational study].
Maev IV; Okhlobystina OZ; Khalif IL; Andreev DN
Ter Arkh; 2023 Feb; 95(1):38-51. PubMed ID: 37167114
[TBL] [Abstract][Full Text] [Related]
12. Epidemiological, Clinical, and Psychological Characteristics of Individuals with Self-reported Irritable Bowel Syndrome Based on the Rome IV vs Rome III Criteria.
Black CJ; Yiannakou Y; Houghton LA; Ford AC
Clin Gastroenterol Hepatol; 2020 Feb; 18(2):392-398.e2. PubMed ID: 31154027
[TBL] [Abstract][Full Text] [Related]
13. Rome III vs Rome IV criteria for irritable bowel syndrome: A comparison of clinical characteristics in a large cohort study.
Vork L; Weerts ZZRM; Mujagic Z; Kruimel JW; Hesselink MAM; Muris JWM; Keszthelyi D; Jonkers DMAE; Masclee AAM
Neurogastroenterol Motil; 2018 Feb; 30(2):. PubMed ID: 28804974
[TBL] [Abstract][Full Text] [Related]
14. Quality of life and sleep in individuals with irritable bowel syndrome according to different diagnostic criteria and inflammatory bowel diseases: A comparison using data from a population-based survey.
Schwille-Kiuntke J; Ittermann T; Schmidt CO; Grabe HJ; Lerch MM; Völzke H; Rieger MA; Enck P; Schauer B
Z Gastroenterol; 2022 Mar; 60(3):299-309. PubMed ID: 35263783
[TBL] [Abstract][Full Text] [Related]
15. Patients with irritable bowel syndrome are more burdened by co-morbidity and worry about serious diseases than healthy controls--eight years follow-up of IBS patients in primary care.
Faresjö Å; Grodzinsky E; Hallert C; Timpka T
BMC Public Health; 2013 Sep; 13():832. PubMed ID: 24025070
[TBL] [Abstract][Full Text] [Related]
16. The Prevalence of Constipation and Irritable Bowel Syndrome in Parkinson's Disease Patients According to Rome III Diagnostic Criteria.
Mishima T; Fukae J; Fujioka S; Inoue K; Tsuboi Y
J Parkinsons Dis; 2017; 7(2):353-357. PubMed ID: 28157108
[TBL] [Abstract][Full Text] [Related]
17. Validation of the Rome III criteria for the diagnosis of irritable bowel syndrome in secondary care.
Ford AC; Bercik P; Morgan DG; Bolino C; Pintos-Sanchez MI; Moayyedi P
Gastroenterology; 2013 Dec; 145(6):1262-70.e1. PubMed ID: 23994201
[TBL] [Abstract][Full Text] [Related]
18. [Prevalence of combination of functional dyspepsia and irritable bowel syndrome: a meta-analysis of studies using the Rome III-IV Criteria].
Andreev DN; Bordin DS; Vyuchnova ES; Lebedeva EG; Dicheva DT; Umyarova RM; Maev IV
Ter Arkh; 2022 Oct; 94(9):1099-1108. PubMed ID: 36286762
[TBL] [Abstract][Full Text] [Related]
19. Quantifying Rome symptoms for diagnosis of the irritable bowel syndrome.
Chang JY; Almazar AE; Richard Locke G; Larson JJ; Atkinson EJ; Talley NJ; Saito YA
Neurogastroenterol Motil; 2018 Sep; 30(9):e13356. PubMed ID: 29701271
[TBL] [Abstract][Full Text] [Related]
20. Diagnosing irritable bowel syndrome: poor agreement between general practitioners and the Rome II criteria.
Vandvik PO; Aabakken L; Farup PG
Scand J Gastroenterol; 2004 May; 39(5):448-53. PubMed ID: 15180182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
